Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene versus letrozole with metformin in anovulatory infertility
IRCT138807262604N1Phase 3
Key facts
- Status
- Completed
- Start
- Apr 2007
- Countries
- 1
- Sponsor
- Research and Clinical Center for Infertility
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Conditions
- female infertilitypolycystic ovary syndrome (PCOS)anovulation
01
Overview
Phase 3, randomised, open-label trial in female infertility, polycystic ovary syndrome (PCOS) and anovulation comparing Clomiphene + metformin with Letrozole + metformin (2 arms). Started Apr 2007; status: completed.
02
Design
2 arms- Study design
- RandomizedOpen-label
Clomiphene + metformin
Participants receive clomiphene in combination with metformin.
Letrozole + metformin
Participants receive letrozole in combination with metformin.
03
Who it enrols
Adult women with polycystic ovary syndrome and anovulatory infertility who were resistant to clomiphene and had normal liver, kidney, and thyroid function. Recent use of clomiphene or metformin within the previous 2 months was excluded.
Beyond the preview
Go deeper on IRCT138807262604N1.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138807262604N1.